Ciprofloxacin
Ciprofloxacin is an oral antibiotic of the quinolone type.
Information about Ciprofloxacin[edit]
Ciprofloxacin is a second generation fluoroquinolone antibiotic that is widely used in the therapy of mild-to-moderate urinary and respiratory tract infections caused by susceptible organisms.
Liver safety of Ciprofloxacin[edit]
Ciprofloxacin has been linked to rare but convincing instances of liver injury that can be severe and even fatal.
Mechanism of action of Ciprofloxacin[edit]
Ciprofloxacin (sip" roe flox' a sin) is an oral fluoroquinolone that is used to treat mild-to-moderate urinary and respiratory tract infections. Ciprofloxacin is also used for infectious diarrhea, typhoid fever, uncomplicated gonorrhea, treatment of Neisseria meningitides nasal carriage and prophylaxis against anthrax.
Mechanism of action of Ciprofloxacin[edit]
Like other fluoroquinolones, ciprofloxacin is active against a wide range of aerobic gram-positive and gram-negative organisms. The fluoroquinolones are believed to act by inhibition of type II DNA toposiomerases (gyrases) that are required for synthesis of bacterial mRNAs (transcription) and DNA replication.Ciprofloxacin was approved for use in the United States in 1990 and, currently, approximately 20 million prescriptions are filled yearly.
Dosage and administration for Ciprofloxacin[edit]
Ciprofloxacin is available in multiple oral formulations of 100, 250, 500 and 750 mg tablets and extended release formulations of 500 and 1000 mg tablets. Ciprofloxacin is available generically and under several commercial names including Cipro and Proquin. The usual dose is 250 to 500 mg every 12 hours. Oral formulations are recommended for mild-to-moderate infections due to susceptible organisms, including urinary tract infections, sinusitis, bronchitis, skin infections, urethral and cervical infections. Intravenous formulations are available for moderate to severe infections, including pneumonia, sinusitis, septicemia, intraabdominal and bone and joint infections, the usual dosages being 200 to 400 mg IV every 8 hours. Oral therapy is typically continued for 7 to 10 days, but both shorter and longer courses are used.
Side effects of Ciprofloxacin[edit]
Common side effects include gastrointestinal upset, headaches, skin rash and allergic reactions. Less common, but more severe side effects include prolongation of the QT interval, seizures, hallucinations, tendon rupture, angioedema, Stevens Johnson syndrome and photosensitivity.
List of flouroquinolones[edit]
| Piperazines | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| Drugs used for diseases of the ear (S02) | ||||||
|---|---|---|---|---|---|---|
|
| GABA receptor modulators | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
- Pages with broken file links
- 1,4-di-hydro-7-(1-piperazinyl)-4-oxo-3-quinolinecarboxylic acids
- Bayer brands
- Cyclopropyl compounds
- CYP1A2 inhibitors
- CYP3A4 inhibitors
- Dermatoxins
- Fluoroquinolone antibiotics
- GABAA receptor negative allosteric modulators
- Nephrotoxins
- Novartis brands
- Ophthalmology drugs
- Otologicals
- World Health Organization essential medicines
- 1-Piperazinyl compounds